Pipemidic Acid

Pipemidic Acid is a quinolone antibacterial agent. Pipemidic Acid is used in the treatment of urinary teact infection


Adult Dose
Dose: 400 mg
Single Dose: 400 (400)
Frequency: 12 hourly
Route: PO
Instructions: For 7-10 Days
Neonatal
Paedriatic
Characteristics
Pipemidic Acid also known as Piperamic acid. . It is of Semi Synthetic origin and belongs to Quinolone. It belongs to DNA Gyrase inhibitor pharmacological group on the basis of mechanism of action and also classified in Antibacterial pharmacological group.The Molecular Weight of Pipemidic Acid is 303.30.
Contraindications
Pipemidic Acid is contraindicated in conditions like Pregnancy,Hypersensitivity to any component of product.
Effects
The severe or irreversible adverse effects of Pipemidic Acid, which give rise to further complications include Leucopenia.The symptomatic adverse reactions produced by Pipemidic Acid are more or less tolerable and if they become severe, they can be treated symptomatically, these include Dizziness, Headache, Fatigue, Nausea, Vomiting, Diarrhea, Fever, Abdominal pain, Urticaria, Pruritus, StomatitisX.
Indications
Pipemidic Acid is primarily indicated in conditions like Bacterial infections, Dysenteries, Enteritis, Urinary tract infection.
Interactions
Pipemidic Acid is known to interact with other drugs, the details of drug interactions is as follows:DrugDetailsSeverityOnsetManagementCaffeineTheophylline These interactions are sometimes beneficial and sometimes may pose threats to life. Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.
Interfrence
Risks
Drug should not be given to Pregnant Mothers, and Neonates.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.
Storage
Warnings
Pipemedic acid is not recommended for use in patients with severe renal faliure (creatinine clearance below 10 ml/min) since urinary levels may not be adequate for therapy and, in some patients, increased drug levels in the blood and cerebrospinal fluid may occur.
Back to List

Any information that appears on this website page is provided for the purpose of general information. This website has been compiled in good faith by HMIS.Online. However, no guarantee is made as to the completeness, validity or accuracy of the information it contains.